drugset / Trial / NCT07357545
Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the immunogenicity and safety of different post-exposure prophylaxis (PEP) schedules of Sinovac rabies vaccine, in comparison with a marked rabies vaccinein china, in subjects aged 10-60 years old.
Timeline
- Start
- 2021-08-27
- Primary completion
- 2022-09-21
- Completion
- 2023-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Marketed rabies vaccine | Vaccine | — | — |
| Subject | Sinovac rabies vaccine | Vaccine | — | — |
Indications
No indication recorded.